Firalis is a biotechnology company that develops innovative biomarker-based diagnostic kits and offers contract research services to pharmaceutical actors. Activities are performed in ISO 17025 accredited, and ISO 13485/ISO 9001 compliant facilities. Firalis is pleased to offer an array of services to support biomarker discovery, development, and regulatory qualification, including:
- Development of critical reagents
- GMP manufacturing of assay kits (ISO 13485)
- Method development and assay validation on different platforms
- Bio-analysis of samples in an accredited environment (ISO 17025)